Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA’s Woodcock to Head Office of Pharmaceutical Quality; New Details Emerge

This article was originally published in RPM Report

Executive Summary

FDA’s proposed Office of Pharmaceutical Quality will be initially headed by CDER Director Janet Woodcock. OPQ would hold responsibility over the manufacturing quality of a drug or biologics throughout a product’s lifecycle; eight offices will oversee activities from policy development to surveillance.

Advertisement

Related Content

Woodcock’s Passion Project: CDER Chief Shifts Duties To Lead Quality Office
CDER Office of Pharmaceutical Quality Launches; Initial Impact On Manufacturers Is Minimal
CDER Office of Product Quality Ready To Go: New Structure Sends Strong Signal To Industry
CDER’s New Quality Office Still Awaiting Final Sign Offs
FDA’s Call for Quality: Revamped GMP Initiative Stresses Cost Savings
FDA’s Call for Quality: Revamped GMP Initiative Stresses Cost Savings
Growing Pains for Generic Drugs: OGD Gains Respect, But Loses Geba
Getting Organized for GDUFA: FDA Elevates Generic Review Activities Under New Director Geba

Topics

Advertisement
UsernamePublicRestriction

Register

PS079669

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel